沉默酰基辅酶A-胆固醇酰基转移酶1基因对人前列腺癌细胞生物学行为的影响

摘要
图/表
参考文献(20)
相关文章 (10)

全文: PDF (926 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的观察ACAT1在人前列腺癌PC-3细胞增殖和侵袭迁移中的作用。方法体外培养人前列腺癌PC-3细胞，通过脂质体HiperFect将ACAT1 siRNA转染至人前列腺癌PC-3细胞中沉默酰基辅酶A-胆固醇酰基转移酶1（ACAT1）基因的表达，Real-time PCR验证沉默的效果。利用CFSE染色法分别检测加入无血清1640培养基的空白对照组、加入阴性-siRNA-HiperFect复合物的阴性对照组和加入ACAT1 siRNA-HiperFect复合物的ACAT1组人前列腺癌PC-3细胞的增殖率，比较ACAT1基因沉默前后细胞增殖的变化。利用Transwell小室法检测ACAT1基因沉默前后人前列腺癌PC-3细胞侵袭和迁移能力的变化。结果与空白对照组和阴性对照组比较，ACAT1 siRNA组转染48 h ACAT1 mRNA表达水平最低（P < 0.05）。与阴性对照组和空白对照组比较，ACAT1 siRNA组细胞增殖率下降，侵袭和迁移实验中穿膜细胞数减少，差异有高度统计学意义（P < 0.01）。阴性对照组与空白对照组比较，细胞增殖率、侵袭和迁移能力无变化，差异无统计学意义（P > 0.05）。结论 ACAT1基因干扰能抑制PC-3细胞的增殖，减弱侵袭迁移能力，为探寻前列腺癌发病机制和治疗提供新的思路和手段。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	陈心1 徐细明1 甘园园1 曹德东1 伍龙1 陈志远2

关键词 ：前列腺癌, 酰基辅酶A-胆固醇酰基转移酶1, 小干扰RNA, 生物学行为

Abstract：Objective To observe the effect of ACAT1 on human prostate cancer cells proliferation, invasion and migration. Methods Human prostate cancer cells (PC-3 cells) were cultured, then the expression of ACAT1 gene in PC-3 cells were interfered using Hiperfect transfection reagent, the expression of ACAT1 gene before and after transfection was detected by Real-time PCR. The proliferation rates of PC-3 cells in the blank control group (serum-free 1640 medium added), the negative control group (negative-siRNA-HiperFect complex added) and the ACAT1 group (ACAT1 siRNA-HiperFect complex added) were analyzed by CFSE staining. The changes of cell proliferation before and after ACAT1 gene silencing were compared. Transwell assays were used to evaluate the effect of ACAT1 gene interfering on cells migration and invasion. Results Compared with the blank control group and the negative control group respectively, ACAT1 mRNA expression level reached the lowest level after 48 hours in the ACAT1 siRNA group (P < 0.05). In the ACAT1 siRNA group, compared with the blank control group and the negative control group, proliferation rate of PC-3 cell decreased, the numbers of invasive cell and migration cell reduced, the differences were statistically significant (P < 0.01). Compared between the blank control group and the negative control group, the differences in proliferation rate, invasion and migration ability of human prostate cancer PC-3 cells had no statistically significant (P > 0.05). Conclusion ACAT1 siRNA reduces proliferation, migration and invasion of PC-3 cells, which maybe provide a new idea and strategy for pathogenesis and treatment of prostate cancer.

Key words： Prostate cancer Acyl coenzyme A cholesterol acyltransferase 1 Small interference RNA Biology behaviors

基金资助:国家自然科学基金资助项目（81302133）；
中央高校基本科研业务费专项基金资助项目（2042014kf0149）；
湖北省自然科学基金资助项目（2012FKC143）。

作者简介: 陈心（1981.7－），女，博士，主要研究领域为肿瘤代谢与肿瘤的发病机制与防治。

引用本文:

陈心1 徐细明1 甘园园1 曹德东1 伍龙1 陈志远2. 沉默酰基辅酶A-胆固醇酰基转移酶1基因对人前列腺癌细胞生物学行为的影响[J]. 中国医药导报, 2017, 14(22): 4-7,15.
CHEN Xin1 XU Ximing1 GAN Yuanyuan1 CAO Dedong1 WU Long1 CHEN Zhiyuan2 . Effect of ACAT1 gene knockdown on the biological behavior of the prostate cancer cells. 中国医药导报, 2017, 14(22): 4-7,15.

链接本文:

http://www.yiyaodaobao.com.cn/CN/ 或 http://www.yiyaodaobao.com.cn/CN/Y2017/V14/I22/4

[1] Siegel RL，Miller KD，Jemal A. Cancer statistics，2015 [J]. CA Cancer J Clin，2015，65（1）：5-29.
[2] 刘芳，王依洁，单雄威，等.2型糖尿病对前列腺癌发病风险和预后的影响[J].临床泌尿外科杂志，2016，31（10）：946-949.
[3] Pelton K，Freeman MR，Solomon KR. Cholesterol and prostate cancer [J]. Curr Opin Pharmacol，2012，12（6）：751-759.
[4] Krycer JR，Brown AJ. Cholesterol accumulation in prostate cancer： a classic observation from a modern perspective [J]. Biochim Biophys Acta，2013，1835（2）：219-229.
[5] Bhindi B，Locke J，Alibhai SM，et al. Dissecting the association between metabolic syndrome and prostate cancer risk： analysis of a large clinical cohort [J]. Eur Urol，2015， 67（1）：64-70.
[6] Moon H，Ruelcke JE，Choi E，et al. Diet-induced hypercholesterolemia promotes androgen-independent prostate cancer metastasis via IQGAP1 and caveolin-1 [J]. Oncotarget，2015，6（10）：7438-7453.
[7] Saraon P，Cretu D，Musrap N，et al. Quantitative proteomics reveals that enzymes of the ketogenic pathway are associated with prostate cancer progression [J]. Mol Cell Proteomics，2013，12（6）：1589-1601.
[8] Ribas V，Garcia-Ruiz C，Fernandez-Checa JC. Mitochondria，cholesterol and cancer cell metabolism [J]. Clin Transl Med，2016，5（1）：22.
[9] Platz EA，Till C，Goodman PJ，et al. Men with low serum cholesterol have a lower risk of high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial [J]. Cancer Epidemiol Biomarkers Prev，2009，18（11）：2807-2813.
[10] Morote J，Celma A，Planas J，et al. Role of serum cholesterol and statin use in the risk of prostate cancer detection and tumor aggressiveness [J]. Int J Mol Sci，2014，15（8）：13615-13623.
[11] Schnoeller TJ，Jentzmik F，Schrader AJ，et al. Influence of serum cholesterol level and statin treatment on prostate cancer aggressiveness [J]. Oncotarget，2017. [Epub ahead of print].
[12] Batty GD，Kivimaki M，Clarke R，et al. Modifiable risk factors for prostate cancer mortality in London： forty years of follow-up in the Whitehall study [J]. Cancer Causes Control，2011，22（2）：311-318.
[13] Bansal D，Undela K，D'cruz S，et al. Statin use and risk of prostate cancer： a meta-analysis of observational studies [J]. PLoS One，2012，7（10）：e46691.
[14] Ghosh S. Early steps in reverse cholesterol transport： cholesteryl ester hydrolase and other hydrolases [J]. Curr Opin Endocrinol Diabetes Obes，2012，19（2）：136-141.
[15] Antognelli C，Ferri I，Bellezza G，et al. Glyoxalase 2 drives tumorigenesis in human prostate cells in a mechanism involving androgen receptor and p53-p21 axis [J]. Mol Carcinog，2017. [Epub ahead of print]. DOI：10.1002/ mc.22668.
[16] Garcia-Bermudez J，Birsoy K. Drugging ACAT1 for Cancer Therapy [J]. Mol Cell，2016，64（5）：856-857.
[17] Yang W，Bai Y，Xiong Y，et al. Potentiating the antitumour response of CD8（+）T cells by modulating cholesterol metabolism [J]. Nature，2016，531（7596）：651-655.
[18] Uda S，Accossu S，Spolitu S，et al. A lipoprotein source of cholesteryl esters is essential for proliferation of CEM-CCRF lymphoblastic cell line [J]. Tumour Biol，2012，33（2）：443-453.
[19] Li J，Lee SY，Gu D，et al. Abstract B50：Abrogating cholesterol esterification suppresses pancreatic cancer growth and metastasis mediated by caveolin-1 [J]. Cancer Res，2015，75（13 Supplement）：B50.
[20] Ye K，Wu Y，Sun Y，et al. TLR4 siRNA inhibits proliferation and invasion in colorectal cancer cells by downregulating ACAT1 expression [J]. Life Sci，2016，155（2016）： 133-139.